1,645 results
·
62ms
·
Sources: EU EUDAMED, US FDA
Medical Action Industries
FDA UDI
MEDICAL ACTION INDUSTRIES INC.·10809160023747·
Medical Action Industries
FDA UDI
MEDICAL ACTION INDUSTRIES INC.·10809160011133·Kit: Mediport / IVAD ACCESS 20/Cs
MEDICAL ACTION INDUSTRIES
FDA UDI
MEDICAL ACTION INDUSTRIES INC.·10809160348628·
Medical Action Industries
FDA UDI
MEDICAL ACTION INDUSTRIES INC.·10809160167465·
MAI
FDA UDI
MEDICAL ACTION INDUSTRIES INC.·10809160366363·
Medical Action Industries
FDA UDI
MEDICAL ACTION INDUSTRIES INC.·10809160008621·
Medical Action Industries
FDA UDI
MEDICAL ACTION INDUSTRIES INC.·10809160206102·
THERAPY SUPPLY HOUSE
FDA UDI
MEDICAL ACTION INDUSTRIES INC.·10809160001837·
Medical Action Industries
FDA UDI
MEDICAL ACTION INDUSTRIES INC.·10809160180693·
Medical Action Industries
FDA UDI
MEDICAL ACTION INDUSTRIES INC.·10809160010693·
Medical Action Industries
FDA UDI
MEDICAL ACTION INDUSTRIES INC.·10809160025352·Kit: Port Access DA 20/Cs PILOT
Medical Action Industries
FDA UDI
MEDICAL ACTION INDUSTRIES INC.·10809160007679·
MEDICAL ACTION INDUSTRIES
FDA UDI
MEDICAL ACTION INDUSTRIES INC.·10809160218631·
Medical Action Industries
FDA UDI
MEDICAL ACTION INDUSTRIES INC.·10809160017395·
Active Anthrax Detect Plus Rapid Test
FDA UDI
INBIOS INTERNATIONAL, INC·B379AAP11·
Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
FDA Pre-Market Approval
FDA Class 3
·Access Hybritech PSA Reagents on the Access Immunoassay Systems
Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
FDA Pre-Market Approval
FDA Class 3
·ACCESS HYBRITECH PSA REAGENTS ON THE ACCESS IMMUNOASSAY SYSTEMS
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
FDA Pre-Market Approval
FDA Class 2
·ACCESS HYBRITECH PSA ON THE SYNCHRON LXI 725 SYSTEM
Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
FDA Pre-Market Approval
FDA Class 3
·ACCESS HYBRITECH PSA REAGENTS ON THE ACCESS IMMUNOASSAY SYSTEMS
Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
FDA Pre-Market Approval
FDA Class 3
·ACCESS HYBRITECH PSA REAGENTS ON THE ACCESS IMMUNOASSAY SYSTEMS